4//SEC Filing
Morenstein Scott D 4
Accession 0000899243-18-025415
CIK 0001183765other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 3:11 PM ET
Size
10.5 KB
Accession
0000899243-18-025415
Insider Transaction Report
Form 4
CDK ASSOCIATES, L.L.C.
Director
Transactions
- Purchase
Common Stock
2018-09-25$5.50/sh+545,454$2,999,997→ 1,559,241 total(indirect: By CDK Associates, L.L.C.)
CAXTON CORP
Director
Transactions
- Purchase
Common Stock
2018-09-25$5.50/sh+545,454$2,999,997→ 1,559,241 total(indirect: By CDK Associates, L.L.C.)
Morenstein Scott D
Director
Transactions
- Purchase
Common Stock
2018-09-25$5.50/sh+545,454$2,999,997→ 1,559,241 total(indirect: By CDK Associates, L.L.C.)
Kovner Bruce
Director
Transactions
- Purchase
Common Stock
2018-09-25$5.50/sh+545,454$2,999,997→ 1,559,241 total(indirect: By CDK Associates, L.L.C.)
Footnotes (1)
- [F1]These shares are held by CDK Associates, L.L.C. and may be deemed to be beneficially owned by (i) Scott Morenstein, a Managing Director of Caxton Alternative Management LP, the investment manager of CDK Associates, L.L.C., (ii) Caxton Corporation, the manager of CDK Associates, LLC and (iii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Scott Morenstein serves as a director of the Issuer. Caxton Corporation, Bruce Kovner and CDK Associates, L.L.C. may be considered directors by deputization due to their affiliation with Scott Morenstein. Each Reporting Person disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Molecular Templates, Inc.
CIK 0001183765
Entity typeother
Related Parties
1- filerCIK 0001576113
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 3:11 PM ET
- Size
- 10.5 KB